Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04889079 · ClinicalTrials.gov registry record

Assessing Adolescent Use of Nexplanon Over Time

A clinical trial of Contraception, sponsored by University of Utah.

Active
Registry status
255
Enrollment target
1
Study location

NCT04889079 is a study of Contraception that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 255 participants, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04889079, a study of Contraception, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
255 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study will provide valuable information for clinical and public health offerings, counseling and support for Nexplanon use across stages of adolescence.

Conditions Studied

Interventions

  • BEHAVIORAL Contraceptive use (continuation/switching/discontinuation)

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 255 participants
Start Date 2021-06-06
Est. Completion 2025-05-30

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT04889079

The ClinicalTrials.gov registry entry for NCT04889079 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (43% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Contraceptive use (continuation/switching/discontinuation) is the first listed.

NCT04889079 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT04889079 about?

NCT04889079 is a clinical study titled "Assessing Adolescent Use of Nexplanon Over Time". The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study will provide valuable info...

What is the current status of trial NCT04889079?

This trial is currently active not recruiting. The enrollment target is 255 participants. The study started on 2021-06-06. Estimated completion is 2025-05-30.

What conditions does trial NCT04889079 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT04889079?

The interventions under investigation include: Contraceptive use (continuation/switching/discontinuation) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04889079?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04889079 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.